Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2023 Apr 19;14(4):277. doi: 10.1038/s41419-023-05808-x

Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation

Dezhong Wang 1,2,#, Mengyun Jin 3,#, Xinyu Zhao 1,#, Tianyang Zhao 1, Wei Lin 1, Zhengle He 4, Miaojuan Fan 3, Wei Jin 3, Jie Zhou 1, Lingwei Jin 3, Chao Zheng 1,3, Hui Jin 5, Yushuo Zhao 3, Xiaokun Li 1,2, Lei Ying 4, Yang Wang 4,, Guanghui Zhu 1,3,, Zhifeng Huang 1,
PMCID: PMC10115840  PMID: 37076485

Correction to: Cell Death and Disease 10.1038/s41419-019-1696-9, published online 12 June 2019

The original version of this article contained an error in Figure 5E. The representative image of transmission electron microscope (EM) analysis for FGF1ΔHBS treatment group was accidentally assigned to the Control group when the authors prepared this figure in PowerPoint (bottom line of Figure 5E). The relevant results previously reported as statistically significant remain to be unchanged. The authors note that this mistake doesn’t affect the conclusion in this study. The correct image is given below.graphic file with name 41419_2023_5808_Fig1_HTML.jpg

Contributor Information

Yang Wang, Email: wangydh995@163.com.

Guanghui Zhu, Email: lcylhy@126.com.

Zhifeng Huang, Email: cpu_son@163.com.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES